N/A
Completed N=3,666
Impact on Management of the HEART Risk Score in Chest Pain Patients
Source: ClinicalTrials.gov NCT01756846 ↗Enrolled (actual)
3,666
Serious AEs
20.6%
Results posted
Jan 2019
Primary outcomePrimary: MACE (Major Adverse Cardiac Events) — 405; 345 Participants
Summary
Aim of this study is to quantify the impact of the use of the HEART risk score on patient outcome and on costs in patients with chest pain presenting at the emergency room, as compared to not using the score.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY MACE (Major Adverse Cardiac Events) |
405; 345 | — |
| SECONDARY Cost-effectiveness (Costs, QoL, QALYs) |
0.16; 0.17 | — |
Eligibility Criteria
Inclusion Criteria
- All patients presenting with chest pain to the (cardiac) ED of ten participating Dutch hospitals, older than 18 years.
Exclusion Criteria
- Children (age <18 years) are excluded from study participation. Subjects who are (for whatever reason) not able to fill in questionnaires are excluded from study participation. Legal incapacity of every patient will be assessed by the attending doctor, according to the guidelines of legal incapacity. In case of doubt, consultation of the cardiologist (primary local investigator) will be possible.
Data sourced from ClinicalTrials.gov (NCT01756846). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.